← Leaderboards
Keira Alexis Cohen
Johns Hopkins University
$793,610
Attributed
$793,610
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $164K · FY2018–22$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$793,610 · 1
By mechanism
K08$793,610 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Sanjay Jain$27,871,118
- Gyanu Lamichhane$9,492,958
- Jeffrey Tornheim$4,019,071
- Susan E Dorman$18,489,626
- Eric L Nuermberger$20,859,483
Others in their field
Other Emerging Leaders on “Antibiotics”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$13,685,544
Research focus
AntibioticsDiagnosticBacteriaBaseAdvisory CommitteesBiobankBioinformaticsCausal VariantChemosensitizationChronicBeta-LactamsArtsClinicClinically RelevantClinic VisitsCohortCollectionCommittee MembersComplementCritical CareCycloserineCystic FibrosisDiagnosisDna-Directed Rna Polymerase
Grant awards (5)
Improved Tools for Nontuberculous Mycobacteria Lung Disease$163,990
K08 · FY2022 · HL · contact PI
Improved Tools for Nontuberculous Mycobacteria Lung Disease$161,303
K08 · FY2021 · HL · contact PI
Improved Tools for Nontuberculous Mycobacteria Lung Disease$158,670
K08 · FY2020 · HL · contact PI
Improved Tools for Nontuberculous Mycobacteria Lung Disease$156,089
K08 · FY2019 · HL · contact PI
Improved Tools for Nontuberculous Mycobacteria Lung Disease$153,558
K08 · FY2018 · HL · contact PI